Back Pain Prevalence in Wheelchair Users and Associated Risk Factors

NCT ID: NCT00477568

Last Updated: 2019-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

750 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-11-30

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to determine the prevalence of back pain in permanent wheelchair users (excludes transitory users) in different regions of Spain. Another study objective is the identification of risk factors for back pain in this population. Data collection will be by means of a structured questionnaire which will be validated in a previous pilot study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults with established disability;
* Permanent wheelchair users;
* Having physical and intellectual ability to answer questionnaire.

Exclusion Criteria

* Transitory wheelchair users;
* Diagnosis of inflammatory rheumatic disease, cancer, systemic infection;
* Red flags for systemic disease.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mallorca Institute of Social Affairs

OTHER_GOV

Sponsor Role collaborator

Kovacs Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francisco M. Kovacs

Director of Scientific Department, Kovacs Foundation

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francisco M Kovacs, MD, PhD

Role: STUDY_DIRECTOR

Unidad de la Espalda Kovacs, Hospital Universitario HLA-Moncloa

Juan Noguera, MD

Role: PRINCIPAL_INVESTIGATOR

Instituto de Asuntos Sociales y Deportes de Mallorca, Palma de Mallorca, Spain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fundación Kovacs

Palma de Mallorca, Balearic Islands, Spain

Site Status

Instituto de Asuntos Sociales y Deportes de Mallorca

Palma de Mallorca, Balearic Island, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FK-R-14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.